CLINICAL_TRIALS ClinicalTrials.gov record update

Phase I Study of Adoptive Immunotherapy With CD8+ and CD4+ Memory T Cells Transduced to Express an HA-1-Specific T Cell Receptor (TCR) for Children and Adults With Recurrent Acute Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation (HCT)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03326921
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:28:59.064761+00:00
Published At: 2025-11-14T00:00:00+00:00
Record Updated At: 2025-11-14
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions: ["Juvenile Myelomonocytic Leukemia", "Recurrent Acute Biphenotypic Leukemia", "Recurrent Acute Undifferentiated Leukemia", "Recurrent Childhood Acute Lymphoblastic Leukemia", "Recurrent Childhood Acute Myeloid Leukemia", "Refractory Acute Lymphoblastic Leukemia", "Refractory Adult Acute Lymphoblastic Leukemia", "Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive", "Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm", "Recurrent Myelodysplastic Syndrome", "Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm", "Refractory Myelodysplastic Syndrome", "Acute Undifferentiated Leukemia", "Mixed Phenotype Acute Leukemia", "Recurrent Chronic Myeloid Leukemia, BCR-ABL1 Positive", "Refractory Chronic Myeloid Leukemia, BCR-ABL1 Positive", "Recurrent Acute Lymphoblastic Leukemia", "Recurrent Acute Myeloid Leukemia", "Myelodysplastic Syndrome", "Acute Myeloid Leukemia", "Acute Lymphoblastic Leukemia", "Acute Biphenotypic Leukemia", "Chronic Myeloid Leukemia", "Chronic Myelomonocytic Leukemia", "Minimal Residual Disease", "Recurrent Chronic Myelomonocytic Leukemia", "Recurrent Mixed Phenotype Acute Leukemia", "Leukemia", "Chronic Myeloid Leukemia, BCR-ABL1 Positive"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-11-14"
protocolSection.identificationModule.nctId: "NCT03326921"
protocolSection.identificationModule.officialTitle: "Phase I Study of Adoptive Immunotherapy With CD8+ and CD4+ Memory T Cells Transduced to Express an HA-1-Specific T Cell Receptor (TCR) for Children and Adults With Recurrent Acute Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation (HCT)"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Study condition terms

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.